Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5400464
Reference Type
Journal Article
Subtype
Review
Title
Electroconvulsive Therapy for Depression Comorbid With Myasthenia Gravis: A Case Report and Review of the Literature
Author(s)
Warren, MB; Elder, S; Litchfield, NP
Year
2018
Is Peer Reviewed?
Yes
Journal
Journal of ECT
ISSN:
1095-0680
EISSN:
1533-4112
Volume
34
Issue
1
Page Numbers
50-54
Language
English
PMID
28796013
DOI
10.1097/YCT.0000000000000446
Web of Science Id
WOS:000426556800018
Abstract
OBJECTIVES:
Myasthenia gravis (MG) is a rare but well-described autoimmune disease, which is sometimes comorbid with psychiatric illness. There have been several case reports describing the use of electroconvulsive therapy (ECT) for the treatment of core psychopathology in the context of MG. We sought to review the available published data on ECT in MG and add another case example to the literature.
METHODS:
We performed a PubMed search for relevant articles or case reports in English describing ECT in MG and summarized findings.
RESULTS:
We identified 7 published cases meeting our inclusion criteria in varying detail with different psychiatric presentations and different anesthetic and ECT technique approaches. In addition, we add our own case.
CONCLUSIONS:
Based on the literature and our own clinical experience, ECT seems to be a safe option for the treatment of core psychopathology with comorbid MG as long as appropriate precautions are in place, particularly when choosing an anesthetic approach.
Tags
PFAS
•
PFAS 150
Literature Search August 2019
Web of Science
Not prioritized for screening
Sevoflurane
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity